Diabetogenic effects of nifedipine.
作者信息
Bhatnagar S K, Amin M M, Al-Yusuf A R
出版信息
Br Med J (Clin Res Ed). 1984 Jul 7;289(6436):19. doi: 10.1136/bmj.289.6436.19.
Abstract
摘要
相似文献
1
Diabetogenic effects of nifedipine.硝苯地平的致糖尿病作用。
Br Med J (Clin Res Ed). 1984 Jul 7;289(6436):19. doi: 10.1136/bmj.289.6436.19.
2
[Is nifedipine diabetogenic?].硝苯地平会导致糖尿病吗？
Minerva Endocrinol. 1988 Apr-Jun;13(2):141-2.
3
Diabetogenic effect of nifedipine.硝苯地平的致糖尿病作用。
DICP. 1989 Mar;23(3):236-7. doi: 10.1177/106002808902300309.
4
Diabetogenic effects of nifedipine.硝苯地平的致糖尿病作用。
Br Med J (Clin Res Ed). 1984 Aug 18;289(6442):437-8. doi: 10.1136/bmj.289.6442.437-c.
5
Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects.阿替洛尔与硝苯地平对糖尿病和非糖尿病高血压患者血脂及其他生化指标的比较影响。
Indian J Physiol Pharmacol. 1995 Jul;39(3):237-41.
6
Glycaemic control and exercise tolerance in hypertensive insulin-treated diabetes during nifedipine therapy.硝苯地平治疗期间高血压胰岛素治疗糖尿病患者的血糖控制与运动耐量
Br J Clin Pract. 1987 Jun;41(6):772-8.
7
Nifedipine and nisoldipine in hypertensive diabetics.硝苯地平和尼索地平用于高血压糖尿病患者
J Hum Hypertens. 1991 Dec;5(6):517-22.
8
Nifedipine in angina and blood glucose levels in diabetics.硝苯地平与心绞痛及糖尿病患者的血糖水平
J Assoc Physicians India. 1986 Nov;34(11):773-6.
9
10
[Does long-term blood pressure reduction in patients with essential hypertension improve concomitant metabolic disorders?].[原发性高血压患者长期降压是否能改善伴发的代谢紊乱？]
Med Klin (Munich). 1994 Aug 15;89(8):403-9.
引用本文的文献
1
[Pharmacologic importance of the combination atenolol/nifedipine in hypertensive patients].阿替洛尔/硝苯地平联合用药在高血压患者中的药理学重要性
Drugs. 1998;56 Suppl 2:23-30. doi: 10.2165/00003495-199856002-00003.
2
Metabolic effects of lacidipine: a placebo-controlled study using the euglycaemic hyperinsulinaemic clamp.拉西地平的代谢效应：一项采用正常血糖高胰岛素钳夹技术的安慰剂对照研究。
Br J Clin Pharmacol. 1993 Jan;35(1):40-5.
3
Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension.
Eur J Clin Pharmacol. 1993;44(5):457-62. doi: 10.1007/BF00315543.
4
Calcium channel blocking agents and the heart.钙通道阻滞剂与心脏
Br Med J (Clin Res Ed). 1985 Oct 26;291(6503):1150-2. doi: 10.1136/bmj.291.6503.1150.
5
Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.
Eur J Clin Pharmacol. 1985;29(2):149-54. doi: 10.1007/BF00547413.
6
Disposition and hypoglycaemic action of glipizide in diabetic patients given a single dose of nifedipine.
Eur J Clin Pharmacol. 1987;33(1):81-3. doi: 10.1007/BF00610385.
7
Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.高血压患者在使用钙拮抗剂非洛地平治疗期间的葡萄糖耐量
Br J Clin Pharmacol. 1987 Aug;24(2):145-9. doi: 10.1111/j.1365-2125.1987.tb03155.x.
8
Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations.钙通道拮抗剂。第四部分：副作用、禁忌、药物相互作用及联合用药
Cardiovasc Drugs Ther. 1988 Jul;2(2):177-89. doi: 10.1007/BF00051233.
9
Lack of effect of nicardipine and diltiazem on glucose- and arginine-induced insulin release in obese subjects.尼卡地平和地尔硫䓬对肥胖受试者葡萄糖和精氨酸诱导的胰岛素释放无影响。
Cardiovasc Drugs Ther. 1988 Dec;2(5):669-72. doi: 10.1007/BF00054207.
10
Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients.硝苯地平对高血压血液透析患者碳水化合物和脂质代谢的长期影响。
Klin Wochenschr. 1986 Oct 31;64(21):1124-30. doi: 10.1007/BF01726873.
本文引用的文献
1
Impairment of insulin secretion in man by nifedipine.
Eur J Clin Pharmacol. 1980 Nov;18(5):395-8. doi: 10.1007/BF00636791.
2
Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients.硝苯地平对糖尿病和非糖尿病患者糖耐量及胰岛素分泌的影响。
Curr Med Res Opin. 1980;6(10):690-3. doi: 10.1185/03007998009110082.
3
Hyperglycaemic effect of nifedipine.硝苯地平的高血糖效应。
Br Med J (Clin Res Ed). 1981 Jul 4;283(6283):19-20. doi: 10.1136/bmj.283.6283.19.
Zotero 插件